A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children
Clinical trial NCT02548078 · COMPLETED
Trial details
- NCT number
- NCT02548078
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-09
- Primary completion
- 2017-05-15
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.